{"product_id":"india-coronary-stent-market","title":"India Coronary Stent Market","description":"\u003cp\u003eIndia Coronary Stent Market, By Product Type (Drug Eluting Stents, Bare Metal Stents, Bioresorbable Vascular Scaffold), By Material (Cobalt Chromium, Stainless Steel, Platinum Chromium, Nickel Titanium, Polymer), By End User (Hospitals, Ambulatory Surgical Centers, Cardiac Catheterization Laboratories)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030Coronary stents (CS) are expandable tubular metallic devices, which are introduced into the coronary arteries that shows stenosis due to an underlying atherosclerosis disease. This revascularization procedure is termed as a percutaneous coronary intervention (PCI) or coronary angioplasty with stent placement.\u003c\/p\u003e\n\n\u003cp\u003eThere are main types of stents:Bare metal stents (BMS)Drug eluting stents (DES)Bioresorbable scaffold system (BRS)Drug- Eluting balloons (DEB).DES consists of three components: a metallic stent platform, an active pharmacological drug agent, and a carrier vehicle. Stainless steel or cobalt-chromium is the most common metal and gives long-term mechanical stability to counteract vascular recoil. The drug release is carried out by diffusion through pores in the polymeric coating. While DEB has only antiproliferative drug coating without an underlying metallic structure of the stent, BRS is also devoid of metallic structure and is entirely resorbed in a few months after serving their purpose. Other stents such as bifurcation stents and covered stents are designed for special circumstances such as lesion over vascular bifurcation or coronary artery perforation, respectively.\u003c\/p\u003e\n\n\u003cp\u003eMarket Dynamics\u003c\/p\u003e\n\n\u003cp\u003eThe demand for coronary stents is anticipated to be driven by an ageing population and an increase in the prevalence of risk factors such as cardiovascular diseases (CVDs), complicated lesions, diabetes, obesity, and others. Apart from these governments initiative to reduce the prices of coronary stent by adding them in the list of essential medicines have promoted to shift the customers from the by-pass surgeries to the PCI procedure. For instance, according to report shared on January 13, 2020, the total stents used in India (Indian as well as imported) were 4,50,000 before price cap while they increased in 6,00,000 after the price cap in India.\u003c\/p\u003e\n\n\u003cp\u003eKey features of the study:This report provides an in-depth analysis of the India coronary stent market and provides market size (US$ Million) and compound annual growth rate (CAGR) for the forecast period (2023–2030), considering 2022 as the base yearIt elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this marketThis study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key playersIt profiles key players in the India coronary stent market based on the following parameters–Company highlights, products portfolio, key highlights, financial performance, and strategiesKey companies covered as a part of this study include Abbott Laboratories, Medtronic, Inc, Biosensors Inc, Terumo Corporation, Boston Scientific Inc.,Becton, Dickinson and Company, Cook medicals, B Braun Melsungen AG, SLTL Medical, Endocare, Cardiac Care Products, Invent Bio-med Private Limited, Nano therapeutics pvt ltd, MIV therapeutics.Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tacticsIndia coronary stent market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analystsStakeholders would have ease in decision-making through various strategy matrices used in analyzing the India coronary stent marketDetailed Segmentation:India Coronary Stents MarketBy Product Type:Drug eluting stents\u003c\/p\u003e\n\n\u003cp\u003eBare metal stents\u003c\/p\u003e\n\n\u003cp\u003eBioresorbable vascular scaffoldIndia coronary stent market, By Material:Cobalt Chromium\u003c\/p\u003e\n\n\u003cp\u003eStainless steel\u003c\/p\u003e\n\n\u003cp\u003ePlatinum Chromium\u003c\/p\u003e\n\n\u003cp\u003eNickel Titanium\u003c\/p\u003e\n\n\u003cp\u003ePolymerIndia coronary stent market, By End user:Hospitals\u003c\/p\u003e\n\n\u003cp\u003eAmbulatory Surgical Centers\u003c\/p\u003e\n\n\u003cp\u003eCardiac Catheterization laboratoriesCompany ProfilesAbbott Laboratories* Company Highlights Products Portfolio Key Highlights Financial Performance StrategiesMedtronic, Inc.\u003c\/p\u003e\n\n\u003cp\u003eBiosensors, Inc.\u003c\/p\u003e\n\n\u003cp\u003eTerumo corporation\u003c\/p\u003e\n\n\u003cp\u003eBoston Scientific Inc.\u003c\/p\u003e\n\n\u003cp\u003eBecton, Dickinson and Company\u003c\/p\u003e\n\n\u003cp\u003eCook Medicals\u003c\/p\u003e\n\n\u003cp\u003eB Braun Melsungen AG\u003c\/p\u003e\n\n\u003cp\u003eSLTL Medical\u003c\/p\u003e\n\n\u003cp\u003eEndocare\u003c\/p\u003e\n\n\u003cp\u003eCardiac Care Products\u003c\/p\u003e\n\n\u003cp\u003eInvent Bio-med Private Limited\u003c\/p\u003e\n\n\u003cp\u003eNano therapeutics pvt ltd.\u003c\/p\u003e\n\n\u003cp\u003eMIV therapeutics\u003c\/p\u003e\n\n\u003cp\u003e“*” marked represents similar segmentation in other categories in the respective section\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"May, 2023 \/ 115 Pages \/ MCW16245160","offer_id":47662633550130,"sku":null,"price":5400.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/india-coronary-stent-market","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}